SRRK — Scholar Rock Holding Corporation stock price and chart

Share this page

SRRK

$39.90-1.82%

as of close, Oct 16, 2026

☾ AH $39.90 -1.82%

Scholar Rock Holding CorporationStock · HealthcareRussell 2000 0.2%Nasdaq Composite 0.01%Russell 3000 0.008%US Stock Market 0.008%

PeersMRNALLYMDTUNHJNJTMO

Technical analysis2

Overlay lines0

Addendum charts0

Available history since Jun 1, 2018

VolumeEEEE

20182020202220242026

10.020.030.040.050.060.0050.0M100.0M$39.90

2026-10-16

Price$39.90

MA20$50.24

MA50$46.33

Vol8.8M

What would $1,000 invested in SRRK be worth today? →

SRRK returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $39.90
YTD price return: -9.42%
YTD total return: -9.42%
Next earnings: Nov 13, 2026
Market cap: 4.9B2018-09 650M2026-10 4.9B+647.9% over the window
Enterprise value: 4.6B
Shares outstanding: 121.8M2017-12 4M2026-06 121.8M+2967.2% over the window
52W low: $27.07
52W high: $61.76
From 52W high: -35.40%
From 52W low: +47.40%
52W range: 37%

Volume

Rel volume: 1.33×
30D volume: 2.2M
30D $ vol: 103.6M

Fundamentals

EPS (ttm): -$3.322020-09 -$2.402026-06 -$3.32+38.3% over the window
FCF (ttm): -297M2017-12 -22.1M2026-06 -297M+1244.1% over the window
FCF/share: -$2.442017-12 -$5.572026-06 -$2.44-56.2% over the window
Book value/share: $2.082017-12 -$13.482026-06 $2.08-115.5% over the window
ROE: -161.00%2018-12 -46.3%2026-06 -161.0%+248.0% over the window
ROA: -78.04%2017-12 -40.6%2026-06 -78.0%+92.5% over the window
Debt / equity: 0.77×2018-12 0.232026-06 0.77+243.5% over the window
Current ratio: 7.022017-12 11.782026-06 7.02-40.4% over the window

Growth (CAGR, ttm) · 10Y

Shares: +26.71%2025-06-30 → 2026-06-3096.1M → 121.8M (+26.7% total)+29.37%2023-06-30 → 2026-06-3056.2M → 121.8M (+116.6% total)+28.73%2021-06-30 → 2026-06-3034.5M → 121.8M (+253.4% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Book value/share: -14.14%2025-06-30 → 2026-06-30$2.43 → $2.08 (-14.1% total)-16.66%2023-06-30 → 2026-06-30$3.60 → $2.08 (-42.1% total)-19.82%2021-06-30 → 2026-06-30$6.29 → $2.08 (-66.9% total)n/a
Price: +35.56%2025-10-16 → 2026-10-16$29.44 → $39.90 (+35.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+69.02%2023-10-16 → 2026-10-16$8.26 → $39.90 (+383.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+7.91%2021-10-15 → 2026-10-16$27.27 → $39.90 (+46.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a
Total return: +35.56%2025-10-16 → 2026-10-16$29.44 → $39.90 (+35.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+69.02%2023-10-16 → 2026-10-16$8.26 → $39.90 (+383.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+7.91%2021-10-15 → 2026-10-16$27.27 → $39.90 (+46.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: -12.0×2018-09 -26.012026-10 -11.90-54.2% over the window
Fwd P/E: -16.9×
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 19.1×2018-09 5.822026-10 19.16+228.9% over the window
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: -6.11%2018-12 3.8%2026-06 -4.4%-215.7% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 121.8M ÷ 96.1M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -26.71%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-26.71%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($3.4B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -26.71%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($-252.4M) ÷ today's market cap ($4.9B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: -5.19%2018-12 -15.8%2026-06 -3.8%-76.1% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $-252.4M + TTM dividends $0) ÷ today's market cap ($4.9B). Same caveat as the cash buyback yield.: -5.19%2018-12 -15.8%2026-06 -3.8%-76.1% over the window

Vs own 10Y history

P/S: 98th
P/B: 86th

Bar = where today’s multiple sits in SRRK’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

-1.82%

-5.43%

-19.18%

-22.87%

YTD

-9.42%

+35.53%

+46.31%

Financial statements

Open full SRRK financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+10.48%	+0.43%
JNJ	Johnson & Johnson	-4.38%	+0.90%
ABBV	AbbVie Inc.	+8.73%	+0.71%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+6.97%	-1.29%
MRK	Merck & Co. Inc.	+0.72%	+0.52%
NVS	Novartis AG	+8.59%	+0.16%
TMO	Thermo Fisher Scientific Inc.	+6.41%	-0.93%
AMGN	Amgen Inc.	+14.92%	-0.35%

SRRK — Scholar Rock Holding Corporation price, chart and key statistics